Oxalo Therapeutics, Inc.

New Filing
CIK: 0001739172·Other Technology·DELAWARE·Filed: Jun 6, 2018
Total Offering

Indefinite

Amount Sold

$250,000

Investors

1

First Sale

Jun 5, 2018

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Hatim Hassan
Related Person
Yang Zheng
Related Person

Company

Oxalo Therapeutics, Inc.

1452 EAST 53RD STREET

CHICAGO, IL, 60615

312-906-5342

SEC Filing

0001740010-18-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Oxalo Therapeutics, Inc. Form D Filing — Indefinite | FilingFlow